INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 415m ago
HOUSE PTR15m ago
SEC 13F15m ago
ROBINHOOD CHAIN15m ago
SEC FORM 4/Grant or awardVerified data

Al-Marzooqi Fahed reported VTVT

Director · vTv Therapeutics Inc. · vTv Therapeutics Inc. — Director stock option (right to buy)

Side
A
Value
$210K
Shares
6,000
Price
$35.08
Executed
Jun 26, 2026
Disclosed
Jun 29, 2026
Disclosure timeline3 days from execution to publication · legal deadline 2 business days
Jun 26 executedJun 29, 2026 disclosed

VTVT · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
20/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Grant or award — administrative, little informational value

  • Relative size+12 / 25

    $210K reported value · 44.3% of prior position

  • Filing timing0 / 15

    Disclosed 1 business day after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · VTVT

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    30
    TS
    Tung Michael StephenEVP & CFO
    VTVTvTv Therapeutics Inc.
    Grant or award
    		A$1.66M
    45.0K sh
    		Feb 17, 2026Feb 18, 2026
    traded Feb 17, 2026
    		+1dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001928247-26-000003
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Jun 26, 2026
    Published
    Jun 29, 2026
    Ingested by INSIDER
    Nov 5, 03:50 UTC
    Last re-read
    Nov 5, 03:50 UTC

    Extracted facts

    Filer
    Al-Marzooqi Fahed
    Role
    Director
    Transaction
    Grant or awardAs filed: “A”
    Asset
    vTv Therapeutics Inc. — Director stock option (right to buy)
    Ticker
    VTVT
    Shares
    6,000
    Price per share
    $35.08
    Value
    $210,480
    Execution date (reported)
    Jun 26, 2026
    Owned after transaction
    19.6K shares
    Days from execution to publication
    3

    Calculation

    Value = shares × reported price per share

    • Shares: 6,000
    • Price: $35.08

    = $210,480

    What this establishes

    Al-Marzooqi Fahed filed this Form 4 reporting a grant or award of VTVT on Jun 26, 2026. It became public on Jun 29, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Director
    Al-Marzooqi Fahedcik:0001928247
    Issuer
    vTv Therapeutics Inc.cik:0001641489

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.